Log In
Print this Print this

Biosimilar cetuximab (AP087)

  Manage Alerts
Collapse Summary General Information
Company Aprogen Inc.
DescriptionBiosimilar of cetuximab, chimeric IgG1 mAb targeting EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionBinds epidermal growth factor (EGF) receptor; Antibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today